{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:47:55Z","timestamp":1755218875973,"version":"3.43.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"MasoonDarou Pharmaceutical Company, Tehran, Iran"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00266-025-04929-2","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:10:15Z","timestamp":1747998615000},"page":"3976-3986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Two Botulinum Neurotoxin Type A Preparations (Masport and Dysport) for Upper Face Rhytides: A Randomized Clinical Trial"],"prefix":"10.1007","volume":"49","author":[{"given":"Ghazal","family":"Ghochani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Aghajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Taher","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Zand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Yaseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohsen","family":"Rafizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"4929_CR1","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1097\/01.PRS.0000144795.76040.D3","volume":"114","author":"J Carruthers","year":"2004","unstructured":"Carruthers J, Fagien S, Matarasso SL. consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114:1S-22S. https:\/\/doi.org\/10.1097\/01.PRS.0000144795.76040.D3.","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"4929_CR2","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1111\/jocd.13702","volume":"19","author":"MS Nestor","year":"2020","unstructured":"Nestor MS, Arnold D, Fischer D. The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: key clinical postulates II. J Cosmet Dermatol. 2020;19(11):2785\u2013804. https:\/\/doi.org\/10.1111\/jocd.13702.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"4929_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/jispcd.JISPCD_430_18","volume":"9","author":"V Kattimani","year":"2019","unstructured":"Kattimani V, Tiwari RVC, Gufran K, Wasan B, Shilpa PH, Khader AA. Botulinum toxin application in facial esthetics and recent treatment indications (2013\u20132018). J Int Soc Prev Community Dent. 2019;9(2):99\u2013105. https:\/\/doi.org\/10.4103\/jispcd.JISPCD_430_18.","journal-title":"J Int Soc Prev Community Dent."},{"key":"4929_CR4","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1093\/asj\/sjw285","volume":"37","author":"MAC Kane","year":"2017","unstructured":"Kane MAC, Monheit G. The practical use of Abobotulinumtoxin A in aesthetics. Aesthet Surg J. 2017;37:S12\u20139. https:\/\/doi.org\/10.1093\/asj\/sjw285.","journal-title":"Aesthet Surg J."},{"issue":"12","key":"4929_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2310\/6350.2005.31303","volume":"31","author":"PL Lowe","year":"2005","unstructured":"Lowe PL, Patnaik R, Lowe NJ. A comparison of two botulinum type A toxin preparations for the treatment of glabellar lines: double-blind, randomized. Pilot Study Dermatologic Surg. 2005;31(12):1651\u20134. https:\/\/doi.org\/10.2310\/6350.2005.31303.","journal-title":"Pilot Study. Dermatologic Surg."},{"issue":"5","key":"4929_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00105-011-2148-3","volume":"62","author":"W Prager","year":"2011","unstructured":"Prager W, Wi\u00dfm\u00fcller E, Kollhorst B, B\u00f6er A, Zschocke I. Botulinumtoxin Type A im Halbseitenvergleich. Hautarzt. 2011;62(5):375\u20139. https:\/\/doi.org\/10.1007\/s00105-011-2148-3.","journal-title":"Hautarzt"},{"issue":"11","key":"4929_CR7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1468-3083.2010.03631.x","volume":"24","author":"B Ascher","year":"2010","unstructured":"Ascher B, Talarico S, Cassuto D, et al. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) \u2013 part I: upper facial wrinkles. J Eur Acad Dermatology Venereol. 2010;24(11):1278\u201384. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03631.x.","journal-title":"J Eur Acad Dermatology Venereol."},{"issue":"3","key":"4929_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00266-023-03766-5","volume":"48","author":"K Hedayat","year":"2024","unstructured":"Hedayat K, Ehsani AH. A phase III clinical study of the efficacy and safety of botulinum toxin Type A (MASPORT) with DYSPORT for the treatment of glabellar lines. Aesthet Plast Surg. 2024;48(3):324\u201332. https:\/\/doi.org\/10.1007\/s00266-023-03766-5.","journal-title":"Aesthet Plast Surg"},{"issue":"7","key":"4929_CR9","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1111\/jocd.16289","volume":"23","author":"F Farashi","year":"2024","unstructured":"Farashi F, Ghoncheh M, Ghasemian Moghaddam MR, Soroosh Z. Evaluation of people\u2019s satisfaction with botulinum toxin injection for facial rejuvenation based on age. J Cosmet Dermatol. 2024;23(7):2380\u20135. https:\/\/doi.org\/10.1111\/jocd.16289.","journal-title":"J Cosmet Dermatol"},{"key":"4929_CR10","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332\u2013c332. https:\/\/doi.org\/10.1136\/bmj.c332.","journal-title":"BMJ."},{"issue":"2","key":"4929_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1524-4725.2011.02248.x","volume":"38","author":"TC Flynn","year":"2012","unstructured":"Flynn TC, Carruthers A, Carruthers J, et al. Validated assessment scales for the upper face. Dermatol Surg. 2012;38(2):309\u201319. https:\/\/doi.org\/10.1111\/j.1524-4725.2011.02248.x.","journal-title":"Dermatol Surg"},{"issue":"1","key":"4929_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/pst.1716","volume":"15","author":"L Flight","year":"2016","unstructured":"Flight L, Julious SA. Practical guide to sample size calculations: non-inferiority and equivalence trials. Pharm Stat. 2016;15(1):80\u20139. https:\/\/doi.org\/10.1002\/pst.1716.","journal-title":"Pharm Stat"},{"issue":"S1","key":"4929_CR13","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1007\/s00586-005-1044-x","volume":"15","author":"M Haefeli","year":"2006","unstructured":"Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006;15(S1):S17\u201324. https:\/\/doi.org\/10.1007\/s00586-005-1044-x.","journal-title":"Eur Spine J"},{"key":"4929_CR14","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.2147\/CCID.S420921","volume":"16","author":"S Ali","year":"2023","unstructured":"Ali S, Al Bukhari F, Al Nuaimi K, et al. Consensus statement on the use of botulinum neurotoxin in the middle east. Clin Cosmet Investig Dermatol. 2023;16:2899\u2013909. https:\/\/doi.org\/10.2147\/CCID.S420921.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"12","key":"4929_CR15","first-page":"E56","volume":"13","author":"M Nestor","year":"2020","unstructured":"Nestor M, Cohen JL, Landau M, et al. Onset and duration of AbobotulinumtoxinA for aesthetic use in the upper face: a systematic literature review. J Clin Aesthet Dermatol. 2020;13(12):E56\u201383.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"4","key":"4929_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/PRS.0000000000008966","volume":"149","author":"S Cotofana","year":"2022","unstructured":"Cotofana S, Solish N, Gallagher C, Beleznay K, Hernandez CA, Bertucci V. The anatomy behind eyebrow positioning: a clinical guide based on current anatomic concepts. Plast Reconstr Surg. 2022;149(4):869\u201379. https:\/\/doi.org\/10.1097\/PRS.0000000000008966.","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"4929_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00266-002-2047-1","volume":"26","author":"NW Bulstrode","year":"2002","unstructured":"Bulstrode NW, Grobbelaar AO. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesthet Plast Surg. 2002;26(5):356\u20139. https:\/\/doi.org\/10.1007\/s00266-002-2047-1.","journal-title":"Aesthet Plast Surg"},{"issue":"3\u20134","key":"4929_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/14764170310023254","volume":"5","author":"A Redaelli","year":"2003","unstructured":"Redaelli A, Forte R. How to avoid brow ptosis after forehead treatment with botulinum toxin. J Cosmet Laser Ther. 2003;5(3\u20134):220\u20132. https:\/\/doi.org\/10.1080\/14764170310023254.","journal-title":"J Cosmet Laser Ther"},{"issue":"4","key":"4929_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IOP.0000000000000282","volume":"31","author":"KD Steinsapir","year":"2015","unstructured":"Steinsapir KD, Rootman D, Wulc A, Hwang C. Cosmetic microdroplet botulinum toxin a forehead lift. Ophthalmic Plast Reconstr Surg. 2015;31(4):263\u20138. https:\/\/doi.org\/10.1097\/IOP.0000000000000282.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"4929_CR20","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.1097\/DSS.0000000000001295","volume":"43","author":"DH Jones","year":"2017","unstructured":"Jones DH, Kerscher M, Geister T, Hast MA, Weissenberger P. Efficacy of IncobotulinumtoxinA for the treatment of glabellar frown lines in male subjects: post-hoc analyses from randomized double-blind pivotal studies. Dermatol Surg. 2017;43(2):S235\u201341. https:\/\/doi.org\/10.1097\/DSS.0000000000001295.","journal-title":"Dermatol Surg."},{"issue":"7","key":"4929_CR21","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1524-4725.2006.32191.x","volume":"32","author":"G Kranz","year":"2006","unstructured":"Kranz G, Sycha T, Voller B, Gleiss A, Schinder P, Auff E. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions. Dermatol Surg. 2006;32(7):886\u201390. https:\/\/doi.org\/10.1111\/j.1524-4725.2006.32191.x.","journal-title":"Dermatol Surg"},{"issue":"4","key":"4929_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/archderm.138.4.510","volume":"138","author":"M Alam","year":"2002","unstructured":"Alam M. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative. Arch Dermatol. 2002;138(4):510. https:\/\/doi.org\/10.1001\/archderm.138.4.510.","journal-title":"Arch Dermatol"},{"issue":"9","key":"4929_CR23","first-page":"1013","volume":"10","author":"IJ Vergilis-Kalner","year":"2011","unstructured":"Vergilis-Kalner IJ. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature. J Drugs Dermatol. 2011;10(9):1013\u20135.","journal-title":"J Drugs Dermatol."},{"issue":"5","key":"4929_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00702-016-1522-9","volume":"123","author":"D Dressler","year":"2016","unstructured":"Dressler D, Adib Saberi F, Bigalke H. Botulinum toxin therapy: reduction of injection site pain by pH normalisation. J Neural Transm. 2016;123(5):527\u201331. https:\/\/doi.org\/10.1007\/s00702-016-1522-9.","journal-title":"J Neural Transm"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-04929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-025-04929-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-04929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:41:24Z","timestamp":1754484084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-025-04929-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":24,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4929"],"URL":"https:\/\/doi.org\/10.1007\/s00266-025-04929-2","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"type":"print","value":"0364-216X"},{"type":"electronic","value":"1432-5241"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interests"}},{"value":"The study was approved by the ethics committee of Tehran University of Medical Sciences, Tehran, Iran  (ethics code: IR.TUMS.FARABIH.REC.1402.015). The study was explained to eligible participants and written informed consents were obtained. The study was in accordance with Declaration of Helsinki and the national guidelines and regulations. The protocol of the study was registered in the Iranian clinical trials registry system  (code: IRCT20230727058942N1) as of 12\/18\/2023  and is accessible at .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from each study participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}